Daily News Podcast

FDA approves sufentanil


 

The FDA approves sufentanil for managing pain in patients who are in certified medical health care settings. Also today, Crohn’s disease is tied to anal canal high-risk HPV vaccination. Also today, ultrasound denervation tops radiofrequecy ablation for resistant hypertension, and primary care needs pile up for patients with sickle cell disease.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Screening for intimate partner violence
MDedge Endocrinology
Validation for SLE low-disease definition
MDedge Endocrinology
Heather Yeo: Surgical Residency Attrition
MDedge Endocrinology
AKI linked to later dementia
MDedge Endocrinology
Part B scheme raises concerns
MDedge Endocrinology
Palliative care update highlights role of nonspecialists
MDedge Endocrinology
NSAID risk score validated for CV events
MDedge Endocrinology
TENS improves fibromyalgia pain
MDedge Endocrinology
Is it time to revise ASCVD cardiovascular risk threshold?
MDedge Endocrinology
Samuel Shem: House of God
MDedge Endocrinology